Connect with us

health

COVID-19: Lagos discharges 67 patients, begins chloroquine clinical trial this week

Published




Lagos State will begin clinical trial treatment of COVID-19 using chloroquine as approved by the National Agency for Food and Drug Administration and Control [NAFDAC] this week, says Gbenga Omotoso, the state commissioner for information and strategy.

WuzupNigeria reports that Lagos is the epicentre of the disease which has claimed 176 lives in the country.

Omotoso says the state has secured all necessary approvals to begin the trials. He adds that documentation has been completed and those to be used for trials are ready.

“By next week we should be ready for the trial,” he says.

He adds,

“Also, Lagos got a supply of additional 20,000 testing kits, although we were expecting 40,000. It means that the testing will increase now.”

Meanwhile, Governor Babajide Sanwo-Olu has announced the discharge of 67 more patients, comprising 22 females and 45 males including three foreign nationals; two Indians and a Chinese.

MORE READING!  Speaker Abbas, Deputy Barau, Buhari celebrate Tinubu's 72nd birthday

A statement by Sanwo-Olu’s Chief Press Secretary, Gboyega Akosile, read,

“The patients; 24 from the Mainland Infectious Disease Hospital, Yaba; 22 from Onikan; 11 from Agidingbi; two from Lekki and eight from Lagos University Teaching Hospital isolation centres were discharged having tested negative for COVID-19 in two consecutive readings.”

While commending the dedication of health workers in the state, he said the number of patients successfully managed and discharged from isolation facilities in the state had increased to 608.

MORE READING!  Lagos postpones Easter boat race

He urged the populace to adhere strictly to all safety advisories being the only way to break the chain of the transmission.

Advertisement
Comments



Trending